{"brief_title": "Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia", "brief_summary": "To compare the efficacy and safety of IV tigecycline to IV levofloxacin in the treatment of subjects with CAP requiring hospitalization.", "condition": "Cross Infection", "intervention_type": "Drug", "intervention_name": "Levofloxacin", "criteria": "Inclusion Criteria: - Male and female subjects \u2265 18 years of age and in Bulgaria only \u2264 70 years of age - Subjects hospitalized with CAP with a severity that requires IV antibiotic treatment for at least 7 days - The presence of fever (within 24 hours before randomization) Exclusion Criteria: - Any concomitant condition that, in the opinion of the investigator, would preclude an evaluation of a response or make it unlikely that the contemplated course of therapy could be completed (eg, life expectancy <30 days). - Hospitalization within 14 days before the onset of symptoms. - Residence in a long-term care facility or nursing home \u226514 days before the onset of symptoms.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "70 Years", "healthy_volunteers": "No", "id": "NCT00081575.xml"}